nodes	percent_of_prediction	percent_of_DWPC	metapath
Tretinoin—Alitretinoin—hematologic cancer	0.206	1	CrCtD
Tretinoin—Retinoids—Bexarotene—hematologic cancer	0.16	0.569	CiPCiCtD
Tretinoin—Retinoids—Alitretinoin—hematologic cancer	0.122	0.431	CiPCiCtD
Tretinoin—CRABP1—hematologic cancer	0.0596	0.534	CbGaD
Tretinoin—RARA—hematologic cancer	0.0521	0.466	CbGaD
Tretinoin—Vitamin A—Alitretinoin—hematologic cancer	0.0436	0.333	CrCrCtD
Tretinoin—Acitretin—Alitretinoin—hematologic cancer	0.0436	0.333	CrCrCtD
Tretinoin—Isotretinoin—Alitretinoin—hematologic cancer	0.0436	0.333	CrCrCtD
Tretinoin—CRABP2—Alitretinoin—hematologic cancer	0.0186	0.107	CbGbCtD
Tretinoin—CRABP1—Alitretinoin—hematologic cancer	0.0186	0.107	CbGbCtD
Tretinoin—NR0B1—Vorinostat—hematologic cancer	0.0141	0.0808	CbGbCtD
Tretinoin—RXRG—Bexarotene—hematologic cancer	0.0135	0.0771	CbGbCtD
Tretinoin—RXRA—Bexarotene—hematologic cancer	0.0119	0.0682	CbGbCtD
Tretinoin—RXRB—Bexarotene—hematologic cancer	0.0119	0.0682	CbGbCtD
Tretinoin—RARG—Alitretinoin—hematologic cancer	0.00773	0.0443	CbGbCtD
Tretinoin—RXRG—Alitretinoin—hematologic cancer	0.00773	0.0443	CbGbCtD
Tretinoin—RXRA—Alitretinoin—hematologic cancer	0.00683	0.0392	CbGbCtD
Tretinoin—RXRB—Alitretinoin—hematologic cancer	0.00683	0.0392	CbGbCtD
Tretinoin—RARA—Alitretinoin—hematologic cancer	0.00683	0.0392	CbGbCtD
Tretinoin—RARB—Alitretinoin—hematologic cancer	0.00683	0.0392	CbGbCtD
Tretinoin—NR0B1—Vincristine—hematologic cancer	0.00456	0.0262	CbGbCtD
Tretinoin—NR0B1—Dexamethasone—hematologic cancer	0.00344	0.0197	CbGbCtD
Tretinoin—CYP4A11—Cisplatin—hematologic cancer	0.00204	0.0117	CbGbCtD
Tretinoin—CYP2C18—Ifosfamide—hematologic cancer	0.00184	0.0106	CbGbCtD
Tretinoin—CYP4A11—Dexamethasone—hematologic cancer	0.00165	0.00947	CbGbCtD
Tretinoin—CYP2A6—Methoxsalen—hematologic cancer	0.00123	0.00704	CbGbCtD
Tretinoin—CYP1A1—Methoxsalen—hematologic cancer	0.00105	0.00602	CbGbCtD
Tretinoin—CYP2B6—Thiotepa—hematologic cancer	0.00103	0.0059	CbGbCtD
Tretinoin—CYP1A1—Bortezomib—hematologic cancer	0.000999	0.00572	CbGbCtD
Tretinoin—CYP1A1—Daunorubicin—hematologic cancer	0.000955	0.00547	CbGbCtD
Tretinoin—CYP2A6—Ifosfamide—hematologic cancer	0.000896	0.00514	CbGbCtD
Tretinoin—CYP1A1—Thalidomide—hematologic cancer	0.00087	0.00499	CbGbCtD
Tretinoin—CYP1A1—Dacarbazine—hematologic cancer	0.000748	0.00429	CbGbCtD
Tretinoin—GPRC5A—lung—hematologic cancer	0.00067	0.0548	CbGeAlD
Tretinoin—CYP2C9—Bexarotene—hematologic cancer	0.000656	0.00376	CbGbCtD
Tretinoin—CYP3A7—Ifosfamide—hematologic cancer	0.000613	0.00351	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.000613	0.00351	CbGbCtD
Tretinoin—CYP2A6—Prednisolone—hematologic cancer	0.000597	0.00342	CbGbCtD
Tretinoin—CYP1A1—Dasatinib—hematologic cancer	0.000588	0.00337	CbGbCtD
Tretinoin—CYP3A7—Imatinib—hematologic cancer	0.000585	0.00336	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.000585	0.00336	CbGbCtD
Tretinoin—CYP2B6—Ifosfamide—hematologic cancer	0.000584	0.00334	CbGbCtD
Tretinoin—CYP2C8—Bortezomib—hematologic cancer	0.000576	0.0033	CbGbCtD
Tretinoin—CYP3A5—Daunorubicin—hematologic cancer	0.000573	0.00329	CbGbCtD
Tretinoin—CYP2C9—Idarubicin—hematologic cancer	0.000543	0.00311	CbGbCtD
Tretinoin—CYP3A5—Thalidomide—hematologic cancer	0.000522	0.00299	CbGbCtD
Tretinoin—CYP2B6—Nilotinib—hematologic cancer	0.000507	0.0029	CbGbCtD
Tretinoin—CYP3A5—Teniposide—hematologic cancer	0.000498	0.00286	CbGbCtD
Tretinoin—CYP3A5—Ifosfamide—hematologic cancer	0.00046	0.00263	CbGbCtD
Tretinoin—ALDH1A2—hematopoietic system—hematologic cancer	0.000447	0.0366	CbGeAlD
Tretinoin—CYP2C8—Ifosfamide—hematologic cancer	0.000442	0.00253	CbGbCtD
Tretinoin—CYP3A5—Imatinib—hematologic cancer	0.000439	0.00252	CbGbCtD
Tretinoin—CRABP1—hematopoietic system—hematologic cancer	0.000432	0.0353	CbGeAlD
Tretinoin—CYP2C9—Bortezomib—hematologic cancer	0.000402	0.0023	CbGbCtD
Tretinoin—CYP2C8—Nilotinib—hematologic cancer	0.000384	0.0022	CbGbCtD
Tretinoin—NR0B1—gonad—hematologic cancer	0.000382	0.0312	CbGeAlD
Tretinoin—CYP3A4—Bexarotene—hematologic cancer	0.000381	0.00219	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.000366	0.0021	CbGbCtD
Tretinoin—CYP3A7—Irinotecan—hematologic cancer	0.000366	0.0021	CbGbCtD
Tretinoin—CYP3A4—Busulfan—hematologic cancer	0.000354	0.00203	CbGbCtD
Tretinoin—CYP3A4—Lomustine—hematologic cancer	0.000354	0.00203	CbGbCtD
Tretinoin—CYP3A5—Dasatinib—hematologic cancer	0.000353	0.00202	CbGbCtD
Tretinoin—CYP2A6—Dexamethasone—hematologic cancer	0.000352	0.00202	CbGbCtD
Tretinoin—CYP2C9—Thalidomide—hematologic cancer	0.00035	0.00201	CbGbCtD
Tretinoin—CYP2B6—Irinotecan—hematologic cancer	0.000348	0.002	CbGbCtD
Tretinoin—ALDH1A2—gonad—hematologic cancer	0.00034	0.0278	CbGeAlD
Tretinoin—RARRES1—lung—hematologic cancer	0.000339	0.0277	CbGeAlD
Tretinoin—CYP2C9—Teniposide—hematologic cancer	0.000334	0.00191	CbGbCtD
Tretinoin—CRABP1—gonad—hematologic cancer	0.000328	0.0269	CbGeAlD
Tretinoin—ALDH1A1—hematopoietic system—hematologic cancer	0.000325	0.0266	CbGeAlD
Tretinoin—CYP3A7—Vincristine—hematologic cancer	0.00032	0.00183	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.00032	0.00183	CbGbCtD
Tretinoin—RARRES1—testis—hematologic cancer	0.00032	0.0262	CbGeAlD
Tretinoin—CYP3A4—Thiotepa—hematologic cancer	0.000316	0.00181	CbGbCtD
Tretinoin—CYP2C9—Ifosfamide—hematologic cancer	0.000308	0.00177	CbGbCtD
Tretinoin—CYP1A1—Dexamethasone—hematologic cancer	0.000301	0.00172	CbGbCtD
Tretinoin—CRABP2—gonad—hematologic cancer	0.000297	0.0243	CbGeAlD
Tretinoin—ALDH1A2—blood—hematologic cancer	0.000296	0.0243	CbGeAlD
Tretinoin—CYP2C9—Imatinib—hematologic cancer	0.000294	0.00169	CbGbCtD
Tretinoin—NR0B1—lung—hematologic cancer	0.000292	0.0239	CbGeAlD
Tretinoin—RARG—hematopoietic system—hematologic cancer	0.000285	0.0233	CbGeAlD
Tretinoin—CYP2B6—Cisplatin—hematologic cancer	0.000284	0.00163	CbGbCtD
Tretinoin—NR0B1—testis—hematologic cancer	0.000275	0.0225	CbGeAlD
Tretinoin—CYP3A5—Irinotecan—hematologic cancer	0.000274	0.00157	CbGbCtD
Tretinoin—Isotretinoin—RARA—hematologic cancer	0.000272	0.265	CrCbGaD
Tretinoin—RARA—hematopoietic system—hematologic cancer	0.000268	0.0219	CbGeAlD
Tretinoin—CYP2C9—Nilotinib—hematologic cancer	0.000268	0.00153	CbGbCtD
Tretinoin—ALDH1A2—lung—hematologic cancer	0.00026	0.0213	CbGeAlD
Tretinoin—CRABP2—blood—hematologic cancer	0.000259	0.0212	CbGeAlD
Tretinoin—Alitretinoin—CRABP1—hematologic cancer	0.000254	0.247	CrCbGaD
Tretinoin—ALDH1A1—gonad—hematologic cancer	0.000247	0.0202	CbGeAlD
Tretinoin—CYP3A4—Methoxsalen—hematologic cancer	0.000246	0.00141	CbGbCtD
Tretinoin—ALDH1A2—testis—hematologic cancer	0.000245	0.0201	CbGeAlD
Tretinoin—CYP3A7—Dexamethasone—hematologic cancer	0.000241	0.00138	CbGbCtD
Tretinoin—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.000241	0.00138	CbGbCtD
Tretinoin—CYP3A5—Vincristine—hematologic cancer	0.00024	0.00137	CbGbCtD
Tretinoin—CRABP1—testis—hematologic cancer	0.000237	0.0194	CbGeAlD
Tretinoin—CYP3A4—Bortezomib—hematologic cancer	0.000234	0.00134	CbGbCtD
Tretinoin—RARRES1—lymph node—hematologic cancer	0.000232	0.019	CbGeAlD
Tretinoin—Acitretin—RARA—hematologic cancer	0.000231	0.225	CrCbGaD
Tretinoin—CYP2B6—Dexamethasone—hematologic cancer	0.000229	0.00131	CbGbCtD
Tretinoin—CRABP2—lung—hematologic cancer	0.000227	0.0186	CbGeAlD
Tretinoin—CYP3A4—Daunorubicin—hematologic cancer	0.000224	0.00128	CbGbCtD
Tretinoin—Alitretinoin—RARA—hematologic cancer	0.000222	0.216	CrCbGaD
Tretinoin—CYP3A5—Etoposide—hematologic cancer	0.00022	0.00126	CbGbCtD
Tretinoin—ALDH1A1—blood—hematologic cancer	0.000216	0.0176	CbGeAlD
Tretinoin—CRABP2—testis—hematologic cancer	0.000214	0.0175	CbGeAlD
Tretinoin—CYP2C8—Etoposide—hematologic cancer	0.000211	0.00121	CbGbCtD
Tretinoin—ALDH1A1—bone marrow—hematologic cancer	0.000209	0.0171	CbGeAlD
Tretinoin—RARA—gonad—hematologic cancer	0.000204	0.0167	CbGeAlD
Tretinoin—RARB—lung—hematologic cancer	0.000203	0.0166	CbGeAlD
Tretinoin—CYP3A4—Cytarabine—hematologic cancer	0.000197	0.00113	CbGbCtD
Tretinoin—CYP3A4—Teniposide—hematologic cancer	0.000194	0.00111	CbGbCtD
Tretinoin—CYP2B6—Doxorubicin—hematologic cancer	0.00019	0.00109	CbGbCtD
Tretinoin—ALDH1A1—lung—hematologic cancer	0.000189	0.0155	CbGeAlD
Tretinoin—RARG—blood—hematologic cancer	0.000189	0.0154	CbGeAlD
Tretinoin—RXRG—testis—hematologic cancer	0.000187	0.0153	CbGeAlD
Tretinoin—RXRB—lung—hematologic cancer	0.000186	0.0152	CbGeAlD
Tretinoin—CYP3A5—Dexamethasone—hematologic cancer	0.000181	0.00104	CbGbCtD
Tretinoin—CYP3A4—Ifosfamide—hematologic cancer	0.000179	0.00103	CbGbCtD
Tretinoin—ALDH1A1—testis—hematologic cancer	0.000178	0.0146	CbGeAlD
Tretinoin—ALDH1A2—lymph node—hematologic cancer	0.000178	0.0145	CbGeAlD
Tretinoin—RARA—blood—hematologic cancer	0.000177	0.0145	CbGeAlD
Tretinoin—RXRB—testis—hematologic cancer	0.000176	0.0144	CbGeAlD
Tretinoin—CYP2C8—Dexamethasone—hematologic cancer	0.000174	0.000995	CbGbCtD
Tretinoin—RARA—bone marrow—hematologic cancer	0.000172	0.014	CbGeAlD
Tretinoin—CYP3A4—Imatinib—hematologic cancer	0.000171	0.000981	CbGbCtD
Tretinoin—RARG—lung—hematologic cancer	0.000165	0.0135	CbGeAlD
Tretinoin—CYP3A4—Ruxolitinib—hematologic cancer	0.000161	0.000924	CbGbCtD
Tretinoin—RARG—testis—hematologic cancer	0.000156	0.0128	CbGeAlD
Tretinoin—CYP3A4—Nilotinib—hematologic cancer	0.000156	0.000892	CbGbCtD
Tretinoin—RARA—lung—hematologic cancer	0.000156	0.0127	CbGeAlD
Tretinoin—CYP3A4—Vinorelbine—hematologic cancer	0.000154	0.000884	CbGbCtD
Tretinoin—CYP2C9—Cisplatin—hematologic cancer	0.00015	0.000859	CbGbCtD
Tretinoin—ALDH1A1—Podofilox—Teniposide—hematologic cancer	0.00015	0.217	CbGdCrCtD
Tretinoin—RARA—testis—hematologic cancer	0.000147	0.012	CbGeAlD
Tretinoin—CYP3A4—Triamcinolone—hematologic cancer	0.000141	0.000809	CbGbCtD
Tretinoin—RARB—lymph node—hematologic cancer	0.000139	0.0113	CbGeAlD
Tretinoin—CYP3A4—Dasatinib—hematologic cancer	0.000138	0.000788	CbGbCtD
Tretinoin—CYP3A4—Mitoxantrone—hematologic cancer	0.000136	0.000779	CbGbCtD
Tretinoin—ALDH1A1—Idarubicin—Daunorubicin—hematologic cancer	0.000133	0.194	CbGdCrCtD
Tretinoin—ALDH1A1—lymph node—hematologic cancer	0.000129	0.0106	CbGeAlD
Tretinoin—CYP2C9—Dexamethasone—hematologic cancer	0.000121	0.000694	CbGbCtD
Tretinoin—CYP3A4—Betamethasone—hematologic cancer	0.000121	0.000694	CbGbCtD
Tretinoin—CYP3A4—Prednisolone—hematologic cancer	0.000119	0.000685	CbGbCtD
Tretinoin—RARG—lymph node—hematologic cancer	0.000113	0.00926	CbGeAlD
Tretinoin—CYP3A4—Prednisone—hematologic cancer	0.000113	0.000647	CbGbCtD
Tretinoin—CYP2A6—lung—hematologic cancer	0.00011	0.00898	CbGeAlD
Tretinoin—CYP3A4—Irinotecan—hematologic cancer	0.000107	0.000613	CbGbCtD
Tretinoin—RARA—lymph node—hematologic cancer	0.000106	0.0087	CbGeAlD
Tretinoin—CYP2C8—hematopoietic system—hematologic cancer	0.000106	0.00868	CbGeAlD
Tretinoin—CYP1A1—hematopoietic system—hematologic cancer	9.79e-05	0.00801	CbGeAlD
Tretinoin—CYP3A5—hematopoietic system—hematologic cancer	9.57e-05	0.00784	CbGeAlD
Tretinoin—CYP2B6—hematopoietic system—hematologic cancer	9.52e-05	0.00779	CbGeAlD
Tretinoin—CYP3A4—Vinblastine—hematologic cancer	9.51e-05	0.000545	CbGbCtD
Tretinoin—CYP2C9—hematopoietic system—hematologic cancer	9.42e-05	0.00771	CbGeAlD
Tretinoin—CYP3A4—Vincristine—hematologic cancer	9.35e-05	0.000536	CbGbCtD
Tretinoin—ALDH1A1—Teniposide—Etoposide—hematologic cancer	8.9e-05	0.129	CbGdCrCtD
Tretinoin—ALDH1A1—Podofilox—Etoposide—hematologic cancer	8.9e-05	0.129	CbGdCrCtD
Tretinoin—CYP3A4—Etoposide—hematologic cancer	8.57e-05	0.000491	CbGbCtD
Tretinoin—ALDH1A1—Vinblastine—Vinorelbine—hematologic cancer	7.66e-05	0.111	CbGdCrCtD
Tretinoin—CYP2B6—gonad—hematologic cancer	7.24e-05	0.00592	CbGeAlD
Tretinoin—CYP3A4—hematopoietic system—hematologic cancer	7.19e-05	0.00588	CbGeAlD
Tretinoin—CYP3A4—Dexamethasone—hematologic cancer	7.04e-05	0.000404	CbGbCtD
Tretinoin—CYP2C8—blood—hematologic cancer	7.03e-05	0.00575	CbGeAlD
Tretinoin—CYP1A1—blood—hematologic cancer	6.49e-05	0.00531	CbGeAlD
Tretinoin—CYP3A5—blood—hematologic cancer	6.34e-05	0.00519	CbGeAlD
Tretinoin—CYP2B6—blood—hematologic cancer	6.3e-05	0.00516	CbGeAlD
Tretinoin—CYP2C9—blood—hematologic cancer	6.24e-05	0.00511	CbGeAlD
Tretinoin—ALDH1A1—Vinblastine—Vincristine—hematologic cancer	6.12e-05	0.089	CbGdCrCtD
Tretinoin—CYP3A4—Doxorubicin—hematologic cancer	5.84e-05	0.000335	CbGbCtD
Tretinoin—CYP2C8—testis—hematologic cancer	5.81e-05	0.00476	CbGeAlD
Tretinoin—CYP1A1—lung—hematologic cancer	5.69e-05	0.00465	CbGeAlD
Tretinoin—CYP3A5—lung—hematologic cancer	5.56e-05	0.00455	CbGeAlD
Tretinoin—CYP2B6—lung—hematologic cancer	5.53e-05	0.00452	CbGeAlD
Tretinoin—CYP2B6—testis—hematologic cancer	5.21e-05	0.00427	CbGeAlD
Tretinoin—CYP3A4—blood—hematologic cancer	4.76e-05	0.0039	CbGeAlD
Tretinoin—ALDH1A1—Idarubicin—Epirubicin—hematologic cancer	4.64e-05	0.0674	CbGdCrCtD
Tretinoin—ALDH1A1—Idarubicin—Doxorubicin—hematologic cancer	4.29e-05	0.0624	CbGdCrCtD
Tretinoin—CYP1A1—lymph node—hematologic cancer	3.89e-05	0.00318	CbGeAlD
Tretinoin—Acitretin—ALB—hematologic cancer	2.5e-05	0.0244	CrCbGaD
Tretinoin—Alitretinoin—ABCB1—hematologic cancer	2.29e-05	0.0223	CrCbGaD
Tretinoin—Dermatitis—Cisplatin—hematologic cancer	1.67e-06	2.99e-05	CcSEcCtD
Tretinoin—Erythema—Epirubicin—hematologic cancer	1.66e-06	2.98e-05	CcSEcCtD
Tretinoin—Malnutrition—Epirubicin—hematologic cancer	1.66e-06	2.98e-05	CcSEcCtD
Tretinoin—Diarrhoea—Etoposide—hematologic cancer	1.66e-06	2.97e-05	CcSEcCtD
Tretinoin—Anorexia—Prednisone—hematologic cancer	1.65e-06	2.97e-05	CcSEcCtD
Tretinoin—Eye disorder—Doxorubicin—hematologic cancer	1.65e-06	2.96e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Methotrexate—hematologic cancer	1.65e-06	2.96e-05	CcSEcCtD
Tretinoin—Tinnitus—Doxorubicin—hematologic cancer	1.65e-06	2.96e-05	CcSEcCtD
Tretinoin—Anaemia—Methotrexate—hematologic cancer	1.64e-06	2.95e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Betamethasone—hematologic cancer	1.64e-06	2.95e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Dexamethasone—hematologic cancer	1.64e-06	2.95e-05	CcSEcCtD
Tretinoin—Flushing—Doxorubicin—hematologic cancer	1.64e-06	2.94e-05	CcSEcCtD
Tretinoin—Flatulence—Epirubicin—hematologic cancer	1.64e-06	2.94e-05	CcSEcCtD
Tretinoin—Tension—Epirubicin—hematologic cancer	1.63e-06	2.93e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.63e-06	2.92e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.63e-06	2.92e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Triamcinolone—hematologic cancer	1.62e-06	2.9e-05	CcSEcCtD
Tretinoin—Nervousness—Epirubicin—hematologic cancer	1.62e-06	2.9e-05	CcSEcCtD
Tretinoin—Back pain—Epirubicin—hematologic cancer	1.61e-06	2.89e-05	CcSEcCtD
Tretinoin—Angiopathy—Doxorubicin—hematologic cancer	1.6e-06	2.88e-05	CcSEcCtD
Tretinoin—Malaise—Methotrexate—hematologic cancer	1.6e-06	2.87e-05	CcSEcCtD
Tretinoin—Dizziness—Etoposide—hematologic cancer	1.6e-06	2.87e-05	CcSEcCtD
Tretinoin—Chills—Doxorubicin—hematologic cancer	1.59e-06	2.85e-05	CcSEcCtD
Tretinoin—Urticaria—Dexamethasone—hematologic cancer	1.58e-06	2.84e-05	CcSEcCtD
Tretinoin—Urticaria—Betamethasone—hematologic cancer	1.58e-06	2.84e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.58e-06	2.84e-05	CcSEcCtD
Tretinoin—Dizziness—Prednisolone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Arrhythmia—Doxorubicin—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Asthenia—Triamcinolone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Body temperature increased—Betamethasone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Body temperature increased—Dexamethasone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Abdominal pain—Betamethasone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Abdominal pain—Dexamethasone—hematologic cancer	1.58e-06	2.83e-05	CcSEcCtD
Tretinoin—Nausea—Cisplatin—hematologic cancer	1.57e-06	2.82e-05	CcSEcCtD
Tretinoin—Insomnia—Prednisone—hematologic cancer	1.57e-06	2.82e-05	CcSEcCtD
Tretinoin—Vision blurred—Epirubicin—hematologic cancer	1.57e-06	2.81e-05	CcSEcCtD
Tretinoin—Alopecia—Doxorubicin—hematologic cancer	1.56e-06	2.8e-05	CcSEcCtD
Tretinoin—Paraesthesia—Prednisone—hematologic cancer	1.56e-06	2.8e-05	CcSEcCtD
Tretinoin—Pruritus—Triamcinolone—hematologic cancer	1.55e-06	2.79e-05	CcSEcCtD
Tretinoin—Cough—Methotrexate—hematologic cancer	1.55e-06	2.78e-05	CcSEcCtD
Tretinoin—Mental disorder—Doxorubicin—hematologic cancer	1.55e-06	2.78e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Epirubicin—hematologic cancer	1.54e-06	2.77e-05	CcSEcCtD
Tretinoin—Convulsion—Methotrexate—hematologic cancer	1.54e-06	2.76e-05	CcSEcCtD
Tretinoin—Vomiting—Etoposide—hematologic cancer	1.54e-06	2.76e-05	CcSEcCtD
Tretinoin—Erythema—Doxorubicin—hematologic cancer	1.54e-06	2.76e-05	CcSEcCtD
Tretinoin—Malnutrition—Doxorubicin—hematologic cancer	1.54e-06	2.76e-05	CcSEcCtD
Tretinoin—Anaemia—Epirubicin—hematologic cancer	1.54e-06	2.76e-05	CcSEcCtD
Tretinoin—Agitation—Epirubicin—hematologic cancer	1.53e-06	2.74e-05	CcSEcCtD
Tretinoin—Dyspepsia—Prednisone—hematologic cancer	1.53e-06	2.74e-05	CcSEcCtD
Tretinoin—Rash—Etoposide—hematologic cancer	1.53e-06	2.74e-05	CcSEcCtD
Tretinoin—Dermatitis—Etoposide—hematologic cancer	1.53e-06	2.74e-05	CcSEcCtD
Tretinoin—Headache—Etoposide—hematologic cancer	1.52e-06	2.72e-05	CcSEcCtD
Tretinoin—Flatulence—Doxorubicin—hematologic cancer	1.52e-06	2.72e-05	CcSEcCtD
Tretinoin—Chest pain—Methotrexate—hematologic cancer	1.51e-06	2.71e-05	CcSEcCtD
Tretinoin—Arthralgia—Methotrexate—hematologic cancer	1.51e-06	2.71e-05	CcSEcCtD
Tretinoin—Myalgia—Methotrexate—hematologic cancer	1.51e-06	2.71e-05	CcSEcCtD
Tretinoin—Tension—Doxorubicin—hematologic cancer	1.51e-06	2.71e-05	CcSEcCtD
Tretinoin—Decreased appetite—Prednisone—hematologic cancer	1.51e-06	2.71e-05	CcSEcCtD
Tretinoin—Rash—Prednisolone—hematologic cancer	1.51e-06	2.7e-05	CcSEcCtD
Tretinoin—Dermatitis—Prednisolone—hematologic cancer	1.5e-06	2.7e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.5e-06	2.7e-05	CcSEcCtD
Tretinoin—Malaise—Epirubicin—hematologic cancer	1.5e-06	2.69e-05	CcSEcCtD
Tretinoin—Fatigue—Prednisone—hematologic cancer	1.5e-06	2.68e-05	CcSEcCtD
Tretinoin—Headache—Prednisolone—hematologic cancer	1.5e-06	2.68e-05	CcSEcCtD
Tretinoin—Discomfort—Methotrexate—hematologic cancer	1.5e-06	2.68e-05	CcSEcCtD
Tretinoin—Nervousness—Doxorubicin—hematologic cancer	1.49e-06	2.68e-05	CcSEcCtD
Tretinoin—Syncope—Epirubicin—hematologic cancer	1.49e-06	2.68e-05	CcSEcCtD
Tretinoin—Back pain—Doxorubicin—hematologic cancer	1.49e-06	2.67e-05	CcSEcCtD
Tretinoin—Constipation—Prednisone—hematologic cancer	1.48e-06	2.66e-05	CcSEcCtD
Tretinoin—Palpitations—Epirubicin—hematologic cancer	1.47e-06	2.64e-05	CcSEcCtD
Tretinoin—Confusional state—Methotrexate—hematologic cancer	1.46e-06	2.62e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Epirubicin—hematologic cancer	1.46e-06	2.62e-05	CcSEcCtD
Tretinoin—Dizziness—Triamcinolone—hematologic cancer	1.45e-06	2.61e-05	CcSEcCtD
Tretinoin—Cough—Epirubicin—hematologic cancer	1.45e-06	2.6e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Methotrexate—hematologic cancer	1.45e-06	2.6e-05	CcSEcCtD
Tretinoin—Vision blurred—Doxorubicin—hematologic cancer	1.45e-06	2.6e-05	CcSEcCtD
Tretinoin—Convulsion—Epirubicin—hematologic cancer	1.44e-06	2.58e-05	CcSEcCtD
Tretinoin—Infection—Methotrexate—hematologic cancer	1.44e-06	2.58e-05	CcSEcCtD
Tretinoin—Nausea—Etoposide—hematologic cancer	1.44e-06	2.58e-05	CcSEcCtD
Tretinoin—Hypertension—Epirubicin—hematologic cancer	1.44e-06	2.58e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Prednisone—hematologic cancer	1.43e-06	2.57e-05	CcSEcCtD
Tretinoin—Asthenia—Dexamethasone—hematologic cancer	1.43e-06	2.56e-05	CcSEcCtD
Tretinoin—Asthenia—Betamethasone—hematologic cancer	1.43e-06	2.56e-05	CcSEcCtD
Tretinoin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.43e-06	2.56e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Methotrexate—hematologic cancer	1.42e-06	2.55e-05	CcSEcCtD
Tretinoin—Anaemia—Doxorubicin—hematologic cancer	1.42e-06	2.55e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Methotrexate—hematologic cancer	1.42e-06	2.55e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Prednisone—hematologic cancer	1.42e-06	2.55e-05	CcSEcCtD
Tretinoin—Nausea—Prednisolone—hematologic cancer	1.42e-06	2.54e-05	CcSEcCtD
Tretinoin—Myalgia—Epirubicin—hematologic cancer	1.42e-06	2.54e-05	CcSEcCtD
Tretinoin—Arthralgia—Epirubicin—hematologic cancer	1.42e-06	2.54e-05	CcSEcCtD
Tretinoin—Chest pain—Epirubicin—hematologic cancer	1.42e-06	2.54e-05	CcSEcCtD
Tretinoin—Agitation—Doxorubicin—hematologic cancer	1.41e-06	2.54e-05	CcSEcCtD
Tretinoin—Anxiety—Epirubicin—hematologic cancer	1.41e-06	2.53e-05	CcSEcCtD
Tretinoin—Pruritus—Dexamethasone—hematologic cancer	1.41e-06	2.53e-05	CcSEcCtD
Tretinoin—Pruritus—Betamethasone—hematologic cancer	1.41e-06	2.53e-05	CcSEcCtD
Tretinoin—Skin disorder—Methotrexate—hematologic cancer	1.41e-06	2.53e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.41e-06	2.52e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Methotrexate—hematologic cancer	1.4e-06	2.52e-05	CcSEcCtD
Tretinoin—Discomfort—Epirubicin—hematologic cancer	1.4e-06	2.51e-05	CcSEcCtD
Tretinoin—Vomiting—Triamcinolone—hematologic cancer	1.4e-06	2.5e-05	CcSEcCtD
Tretinoin—Malaise—Doxorubicin—hematologic cancer	1.39e-06	2.49e-05	CcSEcCtD
Tretinoin—Rash—Triamcinolone—hematologic cancer	1.39e-06	2.48e-05	CcSEcCtD
Tretinoin—Dry mouth—Epirubicin—hematologic cancer	1.39e-06	2.48e-05	CcSEcCtD
Tretinoin—Dermatitis—Triamcinolone—hematologic cancer	1.38e-06	2.48e-05	CcSEcCtD
Tretinoin—Anorexia—Methotrexate—hematologic cancer	1.38e-06	2.48e-05	CcSEcCtD
Tretinoin—Syncope—Doxorubicin—hematologic cancer	1.38e-06	2.48e-05	CcSEcCtD
Tretinoin—Urticaria—Prednisone—hematologic cancer	1.38e-06	2.47e-05	CcSEcCtD
Tretinoin—Headache—Triamcinolone—hematologic cancer	1.38e-06	2.47e-05	CcSEcCtD
Tretinoin—Abdominal pain—Prednisone—hematologic cancer	1.37e-06	2.46e-05	CcSEcCtD
Tretinoin—Body temperature increased—Prednisone—hematologic cancer	1.37e-06	2.46e-05	CcSEcCtD
Tretinoin—Confusional state—Epirubicin—hematologic cancer	1.37e-06	2.45e-05	CcSEcCtD
Tretinoin—Diarrhoea—Betamethasone—hematologic cancer	1.36e-06	2.45e-05	CcSEcCtD
Tretinoin—Diarrhoea—Dexamethasone—hematologic cancer	1.36e-06	2.45e-05	CcSEcCtD
Tretinoin—Palpitations—Doxorubicin—hematologic cancer	1.36e-06	2.44e-05	CcSEcCtD
Tretinoin—Oedema—Epirubicin—hematologic cancer	1.36e-06	2.43e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Epirubicin—hematologic cancer	1.36e-06	2.43e-05	CcSEcCtD
Tretinoin—Hypotension—Methotrexate—hematologic cancer	1.36e-06	2.43e-05	CcSEcCtD
Tretinoin—Loss of consciousness—Doxorubicin—hematologic cancer	1.35e-06	2.43e-05	CcSEcCtD
Tretinoin—Infection—Epirubicin—hematologic cancer	1.35e-06	2.42e-05	CcSEcCtD
Tretinoin—Cough—Doxorubicin—hematologic cancer	1.34e-06	2.41e-05	CcSEcCtD
Tretinoin—Shock—Epirubicin—hematologic cancer	1.34e-06	2.4e-05	CcSEcCtD
Tretinoin—Convulsion—Doxorubicin—hematologic cancer	1.33e-06	2.39e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Epirubicin—hematologic cancer	1.33e-06	2.39e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Epirubicin—hematologic cancer	1.33e-06	2.38e-05	CcSEcCtD
Tretinoin—Hypertension—Doxorubicin—hematologic cancer	1.33e-06	2.38e-05	CcSEcCtD
Tretinoin—Tachycardia—Epirubicin—hematologic cancer	1.33e-06	2.38e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.32e-06	2.37e-05	CcSEcCtD
Tretinoin—Skin disorder—Epirubicin—hematologic cancer	1.32e-06	2.36e-05	CcSEcCtD
Tretinoin—Dizziness—Dexamethasone—hematologic cancer	1.32e-06	2.36e-05	CcSEcCtD
Tretinoin—Dizziness—Betamethasone—hematologic cancer	1.32e-06	2.36e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Epirubicin—hematologic cancer	1.31e-06	2.35e-05	CcSEcCtD
Tretinoin—Insomnia—Methotrexate—hematologic cancer	1.31e-06	2.35e-05	CcSEcCtD
Tretinoin—Chest pain—Doxorubicin—hematologic cancer	1.31e-06	2.35e-05	CcSEcCtD
Tretinoin—Arthralgia—Doxorubicin—hematologic cancer	1.31e-06	2.35e-05	CcSEcCtD
Tretinoin—Myalgia—Doxorubicin—hematologic cancer	1.31e-06	2.35e-05	CcSEcCtD
Tretinoin—Anxiety—Doxorubicin—hematologic cancer	1.31e-06	2.34e-05	CcSEcCtD
Tretinoin—Nausea—Triamcinolone—hematologic cancer	1.3e-06	2.34e-05	CcSEcCtD
Tretinoin—Paraesthesia—Methotrexate—hematologic cancer	1.3e-06	2.34e-05	CcSEcCtD
Tretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.3e-06	2.33e-05	CcSEcCtD
Tretinoin—Discomfort—Doxorubicin—hematologic cancer	1.29e-06	2.32e-05	CcSEcCtD
Tretinoin—Anorexia—Epirubicin—hematologic cancer	1.29e-06	2.32e-05	CcSEcCtD
Tretinoin—Dyspnoea—Methotrexate—hematologic cancer	1.29e-06	2.32e-05	CcSEcCtD
Tretinoin—Somnolence—Methotrexate—hematologic cancer	1.29e-06	2.31e-05	CcSEcCtD
Tretinoin—Dry mouth—Doxorubicin—hematologic cancer	1.28e-06	2.3e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Prednisone—hematologic cancer	1.28e-06	2.29e-05	CcSEcCtD
Tretinoin—Dyspepsia—Methotrexate—hematologic cancer	1.28e-06	2.29e-05	CcSEcCtD
Tretinoin—Hypotension—Epirubicin—hematologic cancer	1.27e-06	2.28e-05	CcSEcCtD
Tretinoin—Vomiting—Dexamethasone—hematologic cancer	1.27e-06	2.27e-05	CcSEcCtD
Tretinoin—Vomiting—Betamethasone—hematologic cancer	1.27e-06	2.27e-05	CcSEcCtD
Tretinoin—Confusional state—Doxorubicin—hematologic cancer	1.27e-06	2.27e-05	CcSEcCtD
Tretinoin—Decreased appetite—Methotrexate—hematologic cancer	1.26e-06	2.26e-05	CcSEcCtD
Tretinoin—Rash—Betamethasone—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Rash—Dexamethasone—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Oedema—Doxorubicin—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Dermatitis—Dexamethasone—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Dermatitis—Betamethasone—hematologic cancer	1.26e-06	2.25e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.25e-06	2.25e-05	CcSEcCtD
Tretinoin—Fatigue—Methotrexate—hematologic cancer	1.25e-06	2.24e-05	CcSEcCtD
Tretinoin—Headache—Betamethasone—hematologic cancer	1.25e-06	2.24e-05	CcSEcCtD
Tretinoin—Headache—Dexamethasone—hematologic cancer	1.25e-06	2.24e-05	CcSEcCtD
Tretinoin—Infection—Doxorubicin—hematologic cancer	1.25e-06	2.24e-05	CcSEcCtD
Tretinoin—Asthenia—Prednisone—hematologic cancer	1.25e-06	2.23e-05	CcSEcCtD
Tretinoin—Pain—Methotrexate—hematologic cancer	1.24e-06	2.22e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.24e-06	2.22e-05	CcSEcCtD
Tretinoin—Shock—Doxorubicin—hematologic cancer	1.24e-06	2.22e-05	CcSEcCtD
Tretinoin—Nervous system disorder—Doxorubicin—hematologic cancer	1.23e-06	2.21e-05	CcSEcCtD
Tretinoin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.23e-06	2.21e-05	CcSEcCtD
Tretinoin—Pruritus—Prednisone—hematologic cancer	1.23e-06	2.2e-05	CcSEcCtD
Tretinoin—Insomnia—Epirubicin—hematologic cancer	1.23e-06	2.2e-05	CcSEcCtD
Tretinoin—Tachycardia—Doxorubicin—hematologic cancer	1.23e-06	2.2e-05	CcSEcCtD
Tretinoin—Skin disorder—Doxorubicin—hematologic cancer	1.22e-06	2.19e-05	CcSEcCtD
Tretinoin—Paraesthesia—Epirubicin—hematologic cancer	1.22e-06	2.19e-05	CcSEcCtD
Tretinoin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.21e-06	2.18e-05	CcSEcCtD
Tretinoin—Dyspnoea—Epirubicin—hematologic cancer	1.21e-06	2.17e-05	CcSEcCtD
Tretinoin—Somnolence—Epirubicin—hematologic cancer	1.21e-06	2.16e-05	CcSEcCtD
Tretinoin—Anorexia—Doxorubicin—hematologic cancer	1.2e-06	2.15e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Methotrexate—hematologic cancer	1.2e-06	2.14e-05	CcSEcCtD
Tretinoin—Dyspepsia—Epirubicin—hematologic cancer	1.2e-06	2.14e-05	CcSEcCtD
Tretinoin—Diarrhoea—Prednisone—hematologic cancer	1.19e-06	2.13e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.19e-06	2.13e-05	CcSEcCtD
Tretinoin—Nausea—Dexamethasone—hematologic cancer	1.18e-06	2.12e-05	CcSEcCtD
Tretinoin—Nausea—Betamethasone—hematologic cancer	1.18e-06	2.12e-05	CcSEcCtD
Tretinoin—Decreased appetite—Epirubicin—hematologic cancer	1.18e-06	2.12e-05	CcSEcCtD
Tretinoin—Hypotension—Doxorubicin—hematologic cancer	1.17e-06	2.11e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.17e-06	2.1e-05	CcSEcCtD
Tretinoin—Fatigue—Epirubicin—hematologic cancer	1.17e-06	2.1e-05	CcSEcCtD
Tretinoin—Constipation—Epirubicin—hematologic cancer	1.16e-06	2.08e-05	CcSEcCtD
Tretinoin—Pain—Epirubicin—hematologic cancer	1.16e-06	2.08e-05	CcSEcCtD
Tretinoin—Urticaria—Methotrexate—hematologic cancer	1.15e-06	2.07e-05	CcSEcCtD
Tretinoin—Dizziness—Prednisone—hematologic cancer	1.15e-06	2.06e-05	CcSEcCtD
Tretinoin—Body temperature increased—Methotrexate—hematologic cancer	1.15e-06	2.06e-05	CcSEcCtD
Tretinoin—Abdominal pain—Methotrexate—hematologic cancer	1.15e-06	2.06e-05	CcSEcCtD
Tretinoin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.14e-06	2.05e-05	CcSEcCtD
Tretinoin—Insomnia—Doxorubicin—hematologic cancer	1.14e-06	2.04e-05	CcSEcCtD
Tretinoin—Paraesthesia—Doxorubicin—hematologic cancer	1.13e-06	2.02e-05	CcSEcCtD
Tretinoin—Dyspnoea—Doxorubicin—hematologic cancer	1.12e-06	2.01e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Epirubicin—hematologic cancer	1.12e-06	2.01e-05	CcSEcCtD
Tretinoin—Somnolence—Doxorubicin—hematologic cancer	1.12e-06	2e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.11e-06	1.99e-05	CcSEcCtD
Tretinoin—Dyspepsia—Doxorubicin—hematologic cancer	1.11e-06	1.98e-05	CcSEcCtD
Tretinoin—Vomiting—Prednisone—hematologic cancer	1.1e-06	1.98e-05	CcSEcCtD
Tretinoin—Rash—Prednisone—hematologic cancer	1.09e-06	1.96e-05	CcSEcCtD
Tretinoin—Dermatitis—Prednisone—hematologic cancer	1.09e-06	1.96e-05	CcSEcCtD
Tretinoin—Decreased appetite—Doxorubicin—hematologic cancer	1.09e-06	1.96e-05	CcSEcCtD
Tretinoin—Headache—Prednisone—hematologic cancer	1.09e-06	1.95e-05	CcSEcCtD
Tretinoin—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.08e-06	1.94e-05	CcSEcCtD
Tretinoin—Fatigue—Doxorubicin—hematologic cancer	1.08e-06	1.94e-05	CcSEcCtD
Tretinoin—Urticaria—Epirubicin—hematologic cancer	1.08e-06	1.93e-05	CcSEcCtD
Tretinoin—Constipation—Doxorubicin—hematologic cancer	1.07e-06	1.93e-05	CcSEcCtD
Tretinoin—Pain—Doxorubicin—hematologic cancer	1.07e-06	1.93e-05	CcSEcCtD
Tretinoin—Abdominal pain—Epirubicin—hematologic cancer	1.07e-06	1.92e-05	CcSEcCtD
Tretinoin—Body temperature increased—Epirubicin—hematologic cancer	1.07e-06	1.92e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Methotrexate—hematologic cancer	1.07e-06	1.92e-05	CcSEcCtD
Tretinoin—Asthenia—Methotrexate—hematologic cancer	1.04e-06	1.87e-05	CcSEcCtD
Tretinoin—Feeling abnormal—Doxorubicin—hematologic cancer	1.04e-06	1.86e-05	CcSEcCtD
Tretinoin—Nausea—Prednisone—hematologic cancer	1.03e-06	1.85e-05	CcSEcCtD
Tretinoin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.03e-06	1.84e-05	CcSEcCtD
Tretinoin—Pruritus—Methotrexate—hematologic cancer	1.03e-06	1.84e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Epirubicin—hematologic cancer	1e-06	1.79e-05	CcSEcCtD
Tretinoin—Urticaria—Doxorubicin—hematologic cancer	9.98e-07	1.79e-05	CcSEcCtD
Tretinoin—Abdominal pain—Doxorubicin—hematologic cancer	9.93e-07	1.78e-05	CcSEcCtD
Tretinoin—Body temperature increased—Doxorubicin—hematologic cancer	9.93e-07	1.78e-05	CcSEcCtD
Tretinoin—Diarrhoea—Methotrexate—hematologic cancer	9.93e-07	1.78e-05	CcSEcCtD
Tretinoin—Asthenia—Epirubicin—hematologic cancer	9.74e-07	1.75e-05	CcSEcCtD
Tretinoin—Pruritus—Epirubicin—hematologic cancer	9.61e-07	1.72e-05	CcSEcCtD
Tretinoin—Dizziness—Methotrexate—hematologic cancer	9.59e-07	1.72e-05	CcSEcCtD
Tretinoin—Diarrhoea—Epirubicin—hematologic cancer	9.29e-07	1.67e-05	CcSEcCtD
Tretinoin—Hypersensitivity—Doxorubicin—hematologic cancer	9.25e-07	1.66e-05	CcSEcCtD
Tretinoin—Vomiting—Methotrexate—hematologic cancer	9.22e-07	1.65e-05	CcSEcCtD
Tretinoin—Rash—Methotrexate—hematologic cancer	9.15e-07	1.64e-05	CcSEcCtD
Tretinoin—Dermatitis—Methotrexate—hematologic cancer	9.14e-07	1.64e-05	CcSEcCtD
Tretinoin—Headache—Methotrexate—hematologic cancer	9.09e-07	1.63e-05	CcSEcCtD
Tretinoin—Asthenia—Doxorubicin—hematologic cancer	9.01e-07	1.62e-05	CcSEcCtD
Tretinoin—Dizziness—Epirubicin—hematologic cancer	8.98e-07	1.61e-05	CcSEcCtD
Tretinoin—Pruritus—Doxorubicin—hematologic cancer	8.89e-07	1.59e-05	CcSEcCtD
Tretinoin—Vomiting—Epirubicin—hematologic cancer	8.63e-07	1.55e-05	CcSEcCtD
Tretinoin—Nausea—Methotrexate—hematologic cancer	8.62e-07	1.55e-05	CcSEcCtD
Tretinoin—Diarrhoea—Doxorubicin—hematologic cancer	8.59e-07	1.54e-05	CcSEcCtD
Tretinoin—Rash—Epirubicin—hematologic cancer	8.56e-07	1.54e-05	CcSEcCtD
Tretinoin—Dermatitis—Epirubicin—hematologic cancer	8.55e-07	1.53e-05	CcSEcCtD
Tretinoin—Headache—Epirubicin—hematologic cancer	8.5e-07	1.53e-05	CcSEcCtD
Tretinoin—Dizziness—Doxorubicin—hematologic cancer	8.31e-07	1.49e-05	CcSEcCtD
Tretinoin—Nausea—Epirubicin—hematologic cancer	8.06e-07	1.45e-05	CcSEcCtD
Tretinoin—Vomiting—Doxorubicin—hematologic cancer	7.99e-07	1.43e-05	CcSEcCtD
Tretinoin—Rash—Doxorubicin—hematologic cancer	7.92e-07	1.42e-05	CcSEcCtD
Tretinoin—Dermatitis—Doxorubicin—hematologic cancer	7.91e-07	1.42e-05	CcSEcCtD
Tretinoin—Headache—Doxorubicin—hematologic cancer	7.87e-07	1.41e-05	CcSEcCtD
Tretinoin—Nausea—Doxorubicin—hematologic cancer	7.46e-07	1.34e-05	CcSEcCtD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.8e-07	2.29e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—IDH1—hematologic cancer	5.8e-07	2.28e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—CREBBP—hematologic cancer	5.75e-07	2.27e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTR—hematologic cancer	5.74e-07	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCG2—hematologic cancer	5.74e-07	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—TXN—hematologic cancer	5.73e-07	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.73e-07	2.26e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.73e-07	2.26e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ABCB1—hematologic cancer	5.72e-07	2.25e-05	CbGpPWpGaD
Tretinoin—RXRG—Gene Expression—AKT1—hematologic cancer	5.64e-07	2.22e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CG—hematologic cancer	5.63e-07	2.22e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ENO2—hematologic cancer	5.63e-07	2.22e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.61e-07	2.21e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.56e-07	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—GSTM1—hematologic cancer	5.55e-07	2.19e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—NCOR1—hematologic cancer	5.55e-07	2.19e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.54e-07	2.18e-05	CbGpPWpGaD
Tretinoin—RARB—Gene Expression—AKT1—hematologic cancer	5.53e-07	2.18e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.49e-07	2.16e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTT1—hematologic cancer	5.46e-07	2.15e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CD—hematologic cancer	5.45e-07	2.15e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CB—hematologic cancer	5.44e-07	2.14e-05	CbGpPWpGaD
Tretinoin—RXRA—Developmental Biology—AKT1—hematologic cancer	5.4e-07	2.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.39e-07	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—ALB—hematologic cancer	5.38e-07	2.12e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.38e-07	2.12e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTAP—hematologic cancer	5.36e-07	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NQO1—hematologic cancer	5.36e-07	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CD44—hematologic cancer	5.36e-07	2.11e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—SDC1—hematologic cancer	5.34e-07	2.1e-05	CbGpPWpGaD
Tretinoin—RXRB—Gene Expression—AKT1—hematologic cancer	5.3e-07	2.09e-05	CbGpPWpGaD
Tretinoin—RARA—Gene Expression—AKT1—hematologic cancer	5.3e-07	2.09e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.25e-07	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.24e-07	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.24e-07	2.07e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.24e-07	2.07e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NQO1—hematologic cancer	5.24e-07	2.06e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CD44—hematologic cancer	5.24e-07	2.06e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—CREBBP—hematologic cancer	5.22e-07	2.06e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3R1—hematologic cancer	5.15e-07	2.03e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.11e-07	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.1e-07	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—GSTM1—hematologic cancer	5.09e-07	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—NCOR1—hematologic cancer	5.09e-07	2.01e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CYCS—hematologic cancer	5.07e-07	2e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—HSP90AA1—hematologic cancer	5.04e-07	1.99e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5.03e-07	1.98e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CYCS—hematologic cancer	4.96e-07	1.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CD44—hematologic cancer	4.95e-07	1.95e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NQO1—hematologic cancer	4.95e-07	1.95e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CD—hematologic cancer	4.95e-07	1.95e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NUP98—hematologic cancer	4.95e-07	1.95e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	4.93e-07	1.94e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—MTHFR—hematologic cancer	4.91e-07	1.93e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—ALB—hematologic cancer	4.89e-07	1.93e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.85e-07	1.91e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.81e-07	1.9e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.8e-07	1.89e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.8e-07	1.89e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—FHL2—hematologic cancer	4.78e-07	1.88e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NUP214—hematologic cancer	4.77e-07	1.88e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CB—hematologic cancer	4.75e-07	1.87e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.72e-07	1.86e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PTEN—hematologic cancer	4.7e-07	1.85e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AGRN—hematologic cancer	4.69e-07	1.85e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CYCS—hematologic cancer	4.68e-07	1.85e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3R1—hematologic cancer	4.67e-07	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTR—hematologic cancer	4.67e-07	1.84e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.67e-07	1.84e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—HSP90AA1—hematologic cancer	4.65e-07	1.83e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ENO2—hematologic cancer	4.58e-07	1.81e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CD44—hematologic cancer	4.54e-07	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NQO1—hematologic cancer	4.54e-07	1.79e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.5e-07	1.77e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—EP300—hematologic cancer	4.48e-07	1.77e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.47e-07	1.76e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH2—hematologic cancer	4.45e-07	1.75e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HMMR—hematologic cancer	4.45e-07	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.44e-07	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.44e-07	1.75e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.38e-07	1.72e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTP1—hematologic cancer	4.37e-07	1.72e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—SDC1—hematologic cancer	4.34e-07	1.71e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CB—hematologic cancer	4.31e-07	1.7e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CYCS—hematologic cancer	4.29e-07	1.69e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.27e-07	1.68e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.23e-07	1.67e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.19e-07	1.65e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.18e-07	1.65e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.15e-07	1.63e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ABCB1—hematologic cancer	4.14e-07	1.63e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTP1—hematologic cancer	4.13e-07	1.63e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CG—hematologic cancer	4.12e-07	1.63e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PTEN—hematologic cancer	4.11e-07	1.62e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.11e-07	1.62e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.11e-07	1.62e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MAPK3—hematologic cancer	4.1e-07	1.61e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.1e-07	1.61e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ACP5—hematologic cancer	4.07e-07	1.6e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CA9—hematologic cancer	4.07e-07	1.6e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—NCOR1—hematologic cancer	4.02e-07	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—GSTM1—hematologic cancer	4.02e-07	1.58e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.01e-07	1.58e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.99e-07	1.57e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—MYC—hematologic cancer	3.98e-07	1.57e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—EP300—hematologic cancer	3.92e-07	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.92e-07	1.54e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ABCB1—hematologic cancer	3.91e-07	1.54e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.84e-07	1.51e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—CREBBP—hematologic cancer	3.82e-07	1.51e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—IDH1—hematologic cancer	3.82e-07	1.51e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—GSTM1—hematologic cancer	3.79e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—NCOR1—hematologic cancer	3.79e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.78e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.78e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—TXN—hematologic cancer	3.78e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.78e-07	1.49e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.78e-07	1.49e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PTEN—hematologic cancer	3.73e-07	1.47e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.7e-07	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CD44—hematologic cancer	3.69e-07	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NQO1—hematologic cancer	3.69e-07	1.46e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.66e-07	1.44e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.63e-07	1.43e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CD—hematologic cancer	3.63e-07	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.62e-07	1.43e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.58e-07	1.41e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—ALB—hematologic cancer	3.58e-07	1.41e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—EP300—hematologic cancer	3.56e-07	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.55e-07	1.4e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—MTHFR—hematologic cancer	3.55e-07	1.4e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.51e-07	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CYCS—hematologic cancer	3.49e-07	1.38e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.48e-07	1.37e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.48e-07	1.37e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.47e-07	1.37e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.46e-07	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.46e-07	1.36e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3R1—hematologic cancer	3.42e-07	1.35e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.37e-07	1.33e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—MTHFR—hematologic cancer	3.35e-07	1.32e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.32e-07	1.31e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—PIK3CA—hematologic cancer	3.32e-07	1.31e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—ALB—hematologic cancer	3.28e-07	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NUP98—hematologic cancer	3.26e-07	1.29e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.17e-07	1.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.17e-07	1.25e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CB—hematologic cancer	3.16e-07	1.25e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NUP214—hematologic cancer	3.15e-07	1.24e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.14e-07	1.24e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.12e-07	1.23e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTR—hematologic cancer	3.08e-07	1.21e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.08e-07	1.21e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.08e-07	1.21e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.07e-07	1.21e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.05e-07	1.2e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ENO2—hematologic cancer	3.02e-07	1.19e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.98e-07	1.17e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.98e-07	1.17e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.95e-07	1.16e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.93e-07	1.15e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.92e-07	1.15e-05	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—PIK3CA—hematologic cancer	2.9e-07	1.14e-05	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.9e-07	1.14e-05	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—SDC1—hematologic cancer	2.86e-07	1.13e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.83e-07	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.83e-07	1.12e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.83e-07	1.11e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CG—hematologic cancer	2.82e-07	1.11e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.76e-07	1.09e-05	CbGpPWpGaD
Tretinoin—RXRA—Gene Expression—AKT1—hematologic cancer	2.76e-07	1.09e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PTEN—hematologic cancer	2.73e-07	1.08e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.71e-07	1.07e-05	CbGpPWpGaD
Tretinoin—CYP4A11—Metabolism—AKT1—hematologic cancer	2.71e-07	1.07e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.68e-07	1.06e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—ALB—hematologic cancer	2.65e-07	1.04e-05	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—PIK3CA—hematologic cancer	2.63e-07	1.04e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CD—hematologic cancer	2.62e-07	1.03e-05	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—CREBBP—hematologic cancer	2.61e-07	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—EP300—hematologic cancer	2.6e-07	1.03e-05	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—ALB—hematologic cancer	2.59e-07	1.02e-05	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.58e-07	1.02e-05	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.53e-07	9.98e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PTEN—hematologic cancer	2.5e-07	9.86e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.5e-07	9.86e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CD—hematologic cancer	2.48e-07	9.76e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3R1—hematologic cancer	2.48e-07	9.75e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—ALB—hematologic cancer	2.44e-07	9.63e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CD44—hematologic cancer	2.44e-07	9.6e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NQO1—hematologic cancer	2.44e-07	9.6e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.39e-07	9.44e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—EP300—hematologic cancer	2.39e-07	9.41e-06	CbGpPWpGaD
Tretinoin—CYP2C18—Metabolism—AKT1—hematologic cancer	2.37e-07	9.33e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3R1—hematologic cancer	2.34e-07	9.21e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.34e-07	9.21e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CYCS—hematologic cancer	2.3e-07	9.08e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.29e-07	9.02e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CB—hematologic cancer	2.28e-07	9e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.27e-07	8.95e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—ALB—hematologic cancer	2.24e-07	8.83e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.2e-07	8.69e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CB—hematologic cancer	2.16e-07	8.51e-06	CbGpPWpGaD
Tretinoin—RXRA—Metabolism—AKT1—hematologic cancer	2.15e-07	8.47e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.14e-07	8.45e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.1e-07	8.28e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.03e-07	8.01e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PTEN—hematologic cancer	2.02e-07	7.96e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.98e-07	7.8e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PTEN—hematologic cancer	1.97e-07	7.78e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.95e-07	7.68e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.93e-07	7.59e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—EP300—hematologic cancer	1.93e-07	7.59e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.92e-07	7.58e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—EP300—hematologic cancer	1.88e-07	7.42e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.87e-07	7.36e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.87e-07	7.36e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PTEN—hematologic cancer	1.87e-07	7.35e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.85e-07	7.28e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—ALB—hematologic cancer	1.82e-07	7.19e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—EP300—hematologic cancer	1.78e-07	7.01e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.77e-07	6.96e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.74e-07	6.88e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PTEN—hematologic cancer	1.71e-07	6.74e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.65e-07	6.5e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—EP300—hematologic cancer	1.63e-07	6.43e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.61e-07	6.35e-06	CbGpPWpGaD
Tretinoin—CYP3A7—Metabolism—AKT1—hematologic cancer	1.57e-07	6.2e-06	CbGpPWpGaD
Tretinoin—CYP2A6—Metabolism—AKT1—hematologic cancer	1.44e-07	5.69e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.42e-07	5.62e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.39e-07	5.49e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PTEN—hematologic cancer	1.39e-07	5.48e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.39e-07	5.46e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—EP300—hematologic cancer	1.33e-07	5.23e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—PIK3CA—hematologic cancer	1.32e-07	5.19e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.29e-07	5.06e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.22e-07	4.8e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.21e-07	4.75e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—ALB—hematologic cancer	1.2e-07	4.74e-06	CbGpPWpGaD
Tretinoin—CYP2B6—Metabolism—AKT1—hematologic cancer	1.16e-07	4.59e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.15e-07	4.53e-06	CbGpPWpGaD
Tretinoin—CYP3A5—Metabolism—AKT1—hematologic cancer	1.14e-07	4.48e-06	CbGpPWpGaD
Tretinoin—CYP1A1—Metabolism—AKT1—hematologic cancer	1.07e-07	4.24e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.06e-07	4.19e-06	CbGpPWpGaD
Tretinoin—CYP2C8—Metabolism—AKT1—hematologic cancer	9.85e-08	3.88e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.82e-08	3.87e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PTEN—hematologic cancer	9.18e-08	3.62e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—EP300—hematologic cancer	8.75e-08	3.45e-06	CbGpPWpGaD
Tretinoin—CYP2C9—Metabolism—AKT1—hematologic cancer	8.02e-08	3.16e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.47e-08	2.55e-06	CbGpPWpGaD
Tretinoin—CYP3A4—Metabolism—AKT1—hematologic cancer	5.29e-08	2.08e-06	CbGpPWpGaD
